These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 8503611)

  • 1. [Consensual proposals for the treatment of toxoplasmosis in patients with human immunodeficiency virus infection].
    Leport C; Ambroise-Thomas P; Chêne G; Katlama C; Raffi F; Vildé JL
    Ann Med Interne (Paris); 1993; 144(1):53-6. PubMed ID: 8503611
    [No Abstract]   [Full Text] [Related]  

  • 2. [Update on consensual proposals (1993 February). Role of cotrimoxazole in the primary prevention of toxoplasmosis in patients with HIV infection].
    Leport C; Ambroise-Thomas P; Chêne G; Derouin F; Katlama C; Raffi F; Vildé JL
    Ann Med Interne (Paris); 1993; 144(1):56-7. PubMed ID: 8503612
    [No Abstract]   [Full Text] [Related]  

  • 3. Toxoplasmosis and human immunodeficiency virus (HIV) disease.
    New LC; Holliman RE
    J Antimicrob Chemother; 1994 Jun; 33(6):1079-82. PubMed ID: 7928802
    [No Abstract]   [Full Text] [Related]  

  • 4. [Recommendation for diagnostics and therapy of toxoplasmosis in persons with HIV infection].
    Machala L; Kodym P; Rozsypal H; Stanková M; Sedlácek D
    Klin Mikrobiol Infekc Lek; 2007 Dec; 13(6):248-52. PubMed ID: 18320505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Extracerebral sites of toxoplasmosis in AIDS. Apropos of 2 cases].
    Heudier P; Taillan B; Perrin C; Marty P; Hofman P; Fuzibet JG; Dujardin P
    Ann Med Interne (Paris); 1993; 144(5):341-2. PubMed ID: 8291845
    [No Abstract]   [Full Text] [Related]  

  • 6. Toxoplasmosis in individuals with AIDS.
    Mariuz P; Bosler EM; Luft BJ
    Infect Dis Clin North Am; 1994 Jun; 8(2):365-81. PubMed ID: 8089465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Management of patients infected by the human immunodeficiency virus (HIV). Report of an expert group].
    Delfraissy JF;
    Rev Pneumol Clin; 2002 Dec; 58(6 Pt 1):312-40. PubMed ID: 12545131
    [No Abstract]   [Full Text] [Related]  

  • 8. Preventing opportunistic infections in human immunodeficiency virus-infected persons: implications for the developing world.
    Kaplan JE; Hu DJ; Holmes KK; Jaffe HW; Masur H; De Cock KM
    Am J Trop Med Hyg; 1996 Jul; 55(1):1-11. PubMed ID: 8702012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. National AIDS Treatment Information Project.
    AIDS Treat News; 1995 Apr; (no 220):3. PubMed ID: 11362318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment and prevention of opportunistic infections in patients with human immunodeficiency virus infection.
    Walworth CM; Tavel JA; Kovacs JA
    Adv Intern Med; 1996; 41():31-84. PubMed ID: 8903586
    [No Abstract]   [Full Text] [Related]  

  • 11. Pulmonary toxoplasmosis.
    Campagna AC
    Semin Respir Infect; 1997 Jun; 12(2):98-105. PubMed ID: 9195674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The eye in AIDS.
    Lightman S; Towler HM
    Br J Hosp Med; 1996 Feb 7-20; 55(3):95-99. PubMed ID: 8907870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serological study of the prevalence of toxoplasmosis in 167 patients with acquired immunodeficiency syndrome (AIDS) or chronic lymphadenopathy syndrome (LAS).
    Derouin F; Beauvais B; Larivière M
    Biomed Pharmacother; 1986; 40(6):231-2. PubMed ID: 3790718
    [No Abstract]   [Full Text] [Related]  

  • 14. HIV infection/acquired immunodeficiency syndrome at Siriraj Hospital, 2002: time for secondary prevention.
    Anekthananon T; Ratanasuwan W; Techasathit W; Rongrungruang Y; Suwanagool S
    J Med Assoc Thai; 2004 Feb; 87(2):173-9. PubMed ID: 15061301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Myelopathy and human immunodeficiency virus infection].
    Lleó A; Planella M; Domingo P
    Med Clin (Barc); 1999 Mar; 112(11):423-7. PubMed ID: 10231776
    [No Abstract]   [Full Text] [Related]  

  • 16. Focal neurological disease in patients with acquired immunodeficiency syndrome.
    Skiest DJ
    Clin Infect Dis; 2002 Jan; 34(1):103-15. PubMed ID: 11731953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opportunistic infections in adults with acquired immunodeficiency syndrome: a comparison of clinical and autopsy findings.
    Tang HJ; Liu YC; Yen MY; Chen YS; Wann SR; Lin HH; Lee SS; Lin WR; Huang CK; Su BA; Chang PC; Li CM; Tseng HH
    J Microbiol Immunol Infect; 2006 Aug; 39(4):310-5. PubMed ID: 16926977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurologic manifestations in human immunodeficiency virus infection/acquired immunodeficiency syndrome.
    Kimura S
    Intern Med; 1997 Mar; 36(3):160-1. PubMed ID: 9144004
    [No Abstract]   [Full Text] [Related]  

  • 19. CCR5 delta32 deletion and reduced risk of toxoplasmosis in persons infected with human immunodeficiency virus type 1. The SEROCO-HEMOCO-SEROGEST Study Groups.
    Meyer L; Magierowska M; Hubert JB; Mayaux MJ; Misrahi M; Le Chenadec J; Debre P; Rouzioux C; Delfraissy JF; Theodorou I
    J Infect Dis; 1999 Sep; 180(3):920-4. PubMed ID: 10438395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opportunistic infections in patients with and patients without Acquired Immunodeficiency Syndrome.
    Sepkowitz KA
    Clin Infect Dis; 2002 Apr; 34(8):1098-107. PubMed ID: 11914999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.